fda declares semaglutide shortage resolved february 2025 Wegovy, Ozempic declared over, hitting copycats like Hims & Hers FDA removes semaglutide from drug

Biote is a registered trademark of its owner

Contact your healthcare provider immediately if you experience: Severe, persistent abdominal pain (could indicate pancreatitis, gallbladder disease, or surgical complications) Persistent vomiting preventing fluid intake (risk of dehydration and acute kidney injury) Signs of dehydration (dark urine, dizziness, reduced urination) Symptoms of hypoglycaemia if taking other diabetes medications Unusual fatigue, fever, or wound-related concerns The Ozempic SmPC specifically mentions pancreatitis and gallbladder disease as potential risks that require prompt medical attention

Additionally, GLP-1 medications represent among the highest-cost pharmaceutical interventions per month

Are you considering weight loss medications but feeling confused about all the GLP-1 ads

If you have ever been told you can just try it and see, you are right to pause

Libby AE, Bales ES, Monks J, Orlicky DJ, McManaman JL